University of Alabama at Birmingham — Birmingham, Alabama

Public research footprint of University of Alabama at Birmingham, compiled from the ClinicalTrials.gov public registry.

3,246

Registered studies

924

Active

459

Recruiting now

1,844

Completed

408

Stopped or withdrawn

Most-studied conditions

Myelodysplastic Syndrome · Metastatic Non-Cutaneous Melanoma · Recurrent Melanoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT02196181 — Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer… (Active Not Recruiting)
NCT03712605 — Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After… (Active Not Recruiting)
NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Alabama at Birmingham?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.